NO942181D0 - Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse - Google Patents

Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse

Info

Publication number
NO942181D0
NO942181D0 NO942181A NO942181A NO942181D0 NO 942181 D0 NO942181 D0 NO 942181D0 NO 942181 A NO942181 A NO 942181A NO 942181 A NO942181 A NO 942181A NO 942181 D0 NO942181 D0 NO 942181D0
Authority
NO
Norway
Prior art keywords
oxazinoisoquinoline
derivatives
substituted
processes
preparation
Prior art date
Application number
NO942181A
Other languages
English (en)
Norwegian (no)
Other versions
NO942181L (ro
Inventor
Jeno Kobor
Laszlo Lazar
Imre Huber
Judit Arva
Laszlo Szporny
Bela Kiss
Egon Karpati
Eva Palosi
Zsolt Szombathelyi
Adam Sarkadi
Aniko Gere
Mihaly Bodo
Katalin Csomor
Judit Laszy
Zsolt Szentirmai
Erzsebet Lapis
Sandor Szabo
Gabor Bernath
Ferenc Fulop
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO942181L publication Critical patent/NO942181L/no
Publication of NO942181D0 publication Critical patent/NO942181D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO942181A 1991-12-12 1994-06-10 Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse NO942181D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU913906A HU209393B (en) 1991-12-12 1991-12-12 Process for producing new, substituted oxazinoisoquinoline derivates
PCT/HU1992/000053 WO1993012118A1 (en) 1991-12-12 1992-12-11 Novel substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and process for preparing same

Publications (2)

Publication Number Publication Date
NO942181L NO942181L (ro) 1994-06-10
NO942181D0 true NO942181D0 (no) 1994-06-10

Family

ID=10966001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942181A NO942181D0 (no) 1991-12-12 1994-06-10 Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse

Country Status (9)

Country Link
US (1) US5494909A (ro)
EP (1) EP0620820A1 (ro)
JP (1) JPH07501817A (ro)
AU (1) AU3170593A (ro)
FI (1) FI942675A0 (ro)
HU (1) HU209393B (ro)
NO (1) NO942181D0 (ro)
TW (1) TW219364B (ro)
WO (1) WO1993012118A1 (ro)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103222A1 (en) * 2003-05-19 2004-12-02 Cook Incorporated Implantable medical device with constrained expansion
CA2661448A1 (en) 2005-08-25 2007-03-01 Steven Michael Weiss Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
CN103651435A (zh) * 2013-12-30 2014-03-26 青岛崂乡茶制品有限公司 一种环保的茶叶杀虫剂
CN103651533A (zh) * 2013-12-30 2014-03-26 青岛崂乡茶制品有限公司 一种新型茶叶种植用农药
CN105532682B (zh) * 2016-02-17 2018-03-23 陕西先农生物科技有限公司 一种含藜芦碱植物源杀虫剂组合物及制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191301B (en) * 1984-03-23 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing 1-/hydroxy-methyl/-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- or -thiazino/4,3-a/isoquinoline -derivatives

Also Published As

Publication number Publication date
TW219364B (ro) 1994-01-21
WO1993012118A1 (en) 1993-06-24
AU3170593A (en) 1993-07-19
US5494909A (en) 1996-02-27
FI942675A (fi) 1994-06-07
HU913906D0 (en) 1992-02-28
EP0620820A1 (en) 1994-10-26
HUT63427A (en) 1993-08-30
JPH07501817A (ja) 1995-02-23
FI942675A0 (fi) 1994-06-07
NO942181L (ro) 1994-06-10
HU209393B (en) 1994-05-30

Similar Documents

Publication Publication Date Title
NO934146D0 (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene
FI942913A (fi) Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO973922L (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
IL102638A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL103053A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
IL109703A0 (en) Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
KR950700310A (ko) 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them)
DK0435333T3 (da) Cephalosporinderivater, fremgangsmåde til fremstilling deraf og antimikrobielt præparat indeholdende derivaterne
DK102990A (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
IL102362A0 (en) 4-amino-3-hydroxycarboxylic acid derivatives,their production and pharmaceutical compositions containing them
NO942181D0 (no) Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse
CS124492A3 (en) 2-aminopyrimidine-4-carboxamide derivatives, process of their preparationand pharmaceutical compositions containing said derivatives
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
IL101164A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DK187989D0 (da) Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IL103698A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them